Jaguar Health (JAGX) Non-Current Assets (2014 - 2026)
Jaguar Health's (JAGX) quarterly Non-Current Assets came in at $17.2 million in Q1 2026, down 18.06% year-on-year from $21.0 million in Q1 2025, and up 205.38% on a QoQ basis from -$16.3 million in Q4 2025.
Jaguar Health (JAGX) Non-Current Assets (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Non-Current Assets data on file, last reported at $17.2 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 18.06% year-over-year to $17.2 million in Q1 2026; TTM through Mar 2026 was $41.3 million, a 51.63% decrease from a year earlier, with the FY2025 full-year figure at -$16.3 million, down 177.0% from the prior year.
- Non-Current Assets for Q1 2026 stood at $17.2 million, up from -$16.3 million in the prior quarter.
- Over the last five years, Non-Current Assets for JAGX reached as high as $26.5 million in Q2 2022 and fell as low as -$16.3 million in Q4 2025.
- Historically, Non-Current Assets has averaged $20.3 million across 5 years, with a median of $21.8 million in 2024.
- Across the five-year window, Non-Current Assets advanced 5.06% in 2022 and sank 177.0% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $25.1 million in 2022, then retreated by 9.28% to $22.8 million in 2023, then fell by 6.9% to $21.2 million in 2024, then sank by 177.0% to -$16.3 million in 2025, then jumped by 205.38% to $17.2 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $17.2 million in Q1 2026, -$16.3 million in Q4 2025, and $20.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | 5.70 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 30.30 Mn |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 1.95 Bn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | 14.75 Bn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | 22.66 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | 289.41 Mn |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | 1.96 Bn |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 910.24 Mn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | 285.82 Mn |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 17.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.22 Mn |
| Dec 31, 2025 | -16.35 Mn |
| Sep 30, 2025 | 20.07 Mn |
| Jun 30, 2025 | 20.37 Mn |
| Mar 31, 2025 | 21.02 Mn |
| Dec 31, 2024 | 21.23 Mn |
| Sep 30, 2024 | 21.82 Mn |
| Jun 30, 2024 | 21.35 Mn |
| Mar 31, 2024 | 21.68 Mn |
| Dec 31, 2023 | 22.80 Mn |
| Sep 30, 2023 | 23.32 Mn |
| Jun 30, 2023 | 23.95 Mn |
| Mar 31, 2023 | 24.57 Mn |
| Dec 31, 2022 | 25.13 Mn |
| Sep 30, 2022 | 26.08 Mn |
| Jun 30, 2022 | 26.52 Mn |
| Mar 31, 2022 | 24.43 Mn |
| Dec 31, 2021 | 24.83 Mn |
| Sep 30, 2021 | 35.25 Mn |
| Jun 30, 2021 | 25.25 Mn |